IL146411A0 - Buforin i as a specific inhibitor and therapeutic agent for botulinum toxin b and tetanus neurotoxins - Google Patents
Buforin i as a specific inhibitor and therapeutic agent for botulinum toxin b and tetanus neurotoxinsInfo
- Publication number
- IL146411A0 IL146411A0 IL14641100A IL14641100A IL146411A0 IL 146411 A0 IL146411 A0 IL 146411A0 IL 14641100 A IL14641100 A IL 14641100A IL 14641100 A IL14641100 A IL 14641100A IL 146411 A0 IL146411 A0 IL 146411A0
- Authority
- IL
- Israel
- Prior art keywords
- buforin
- therapeutic agent
- botulinum toxin
- specific inhibitor
- tetanus neurotoxins
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/8146—Metalloprotease (E.C. 3.4.24) inhibitors, e.g. tissue inhibitor of metallo proteinase, TIMP
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Toxicology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13421699P | 1999-05-14 | 1999-05-14 | |
PCT/US2000/012909 WO2000069895A2 (en) | 1999-05-14 | 2000-05-11 | Bufornin 1 as a specific inhibitor and therapeutic agent for botulinum toxin b and tetanus neurotoxins |
Publications (1)
Publication Number | Publication Date |
---|---|
IL146411A0 true IL146411A0 (en) | 2002-07-25 |
Family
ID=22462297
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL14641100A IL146411A0 (en) | 1999-05-14 | 2000-05-11 | Buforin i as a specific inhibitor and therapeutic agent for botulinum toxin b and tetanus neurotoxins |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1179022A2 (ja) |
JP (1) | JP2003502023A (ja) |
AU (1) | AU781608B2 (ja) |
CA (1) | CA2369369A1 (ja) |
IL (1) | IL146411A0 (ja) |
WO (1) | WO2000069895A2 (ja) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7563874B2 (en) | 1998-08-31 | 2009-07-21 | The Regents Of The University Of California | Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins |
KR20020051124A (ko) * | 2000-12-22 | 2002-06-28 | 이한웅 | 부포린 유도체를 포함하는 함암제 |
JP2003009897A (ja) | 2001-07-03 | 2003-01-14 | Keiji Oguma | ボツリヌス毒素の分離・精製法 |
US7700738B2 (en) | 2005-01-27 | 2010-04-20 | The Regents Of The University Of California | Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins |
EP2134749B1 (en) | 2007-03-22 | 2013-11-06 | The Regents of the University of California | Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins |
CA2732003A1 (en) | 2008-07-31 | 2010-02-04 | James D. Marks | Antibodies that neutralize botulinum neurotoxins |
US9243057B2 (en) | 2010-08-31 | 2016-01-26 | The Regents Of The University Of California | Antibodies for botulinum neurotoxins |
CN111100195B (zh) * | 2018-10-25 | 2024-04-09 | 安尼根有限公司 | buforin衍生物及其用途 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9411138D0 (en) * | 1994-06-03 | 1994-07-27 | Microbiological Res Authority | Toxin assay |
WO1998007440A1 (en) * | 1996-08-24 | 1998-02-26 | Samyang Genex Co., Ltd. | A novel antimicrobial peptide isolated from bufo bufo gargarizans |
KR100263583B1 (ko) * | 1997-05-28 | 2000-08-01 | 박종헌 | 항균 펩타이드의 대량 제조방법 및 그에 유용한 플라즈미드 벡타 |
KR100314721B1 (ko) * | 1998-01-22 | 2001-11-23 | 김일웅 | 생물학적 활성이 있는 신규한 펩타이드 |
-
2000
- 2000-05-11 WO PCT/US2000/012909 patent/WO2000069895A2/en active Application Filing
- 2000-05-11 EP EP00948495A patent/EP1179022A2/en not_active Withdrawn
- 2000-05-11 JP JP2000618311A patent/JP2003502023A/ja active Pending
- 2000-05-11 CA CA002369369A patent/CA2369369A1/en not_active Abandoned
- 2000-05-11 AU AU61975/00A patent/AU781608B2/en not_active Ceased
- 2000-05-11 IL IL14641100A patent/IL146411A0/xx unknown
Also Published As
Publication number | Publication date |
---|---|
AU781608B2 (en) | 2005-06-02 |
WO2000069895A2 (en) | 2000-11-23 |
WO2000069895A3 (en) | 2001-08-09 |
CA2369369A1 (en) | 2000-11-23 |
AU6197500A (en) | 2000-12-05 |
EP1179022A2 (en) | 2002-02-13 |
JP2003502023A (ja) | 2003-01-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL146974A0 (en) | Therapeutic composition comprising a botulinum neurotoxin | |
AU7085200A (en) | Botulinum toxin for reducing catecholamine secretion | |
AU2001227930A1 (en) | Clostridial toxin derivatives and methods for treating pain | |
AU3331501A (en) | Botulinum toxin pharmaceutical compositions | |
AU2001265043A1 (en) | Botulinum toxin implant | |
IL118657A0 (en) | Inhibitors for picornavirus proteases | |
IL150964A0 (en) | Protease inhibitors | |
AU2108601A (en) | Salicylamides as serine protease inhibitors | |
IL146411A0 (en) | Buforin i as a specific inhibitor and therapeutic agent for botulinum toxin b and tetanus neurotoxins | |
AU6536200A (en) | Proteases and protease inhibitors | |
EP1180999A4 (en) | RECOMBINANT VACCINE AGAINST BOTULINUM NEUROTOXIN | |
EP1351990A4 (en) | COMPOSITIONS AND METHODS FOR DETECTING PROTEOLYTIC ACTIVITY | |
EP1235577A4 (en) | PROTEASE INHIBITORS | |
IL153421A0 (en) | Protease inhibitors | |
EP1229912A4 (en) | PROTEASE INHIBITORS | |
EP1229914A4 (en) | PROTEASE INHIBITORS | |
EP1231921A4 (en) | PROTEASE INHIBITORS | |
PL366040A1 (en) | Protease inhibitors | |
EP1233771A4 (en) | PROTEASE INHIBITORS | |
HK1044758A1 (zh) | 蛋白酶抑制劑 | |
EP1161237A4 (en) | PROTEASE INHIBITORS | |
EP1229911A4 (en) | PROTEASE INHIBITORS | |
AU1648901A (en) | Neutralizing agent for toxin of microorganism belonging to the genus clostridium | |
GB9914861D0 (en) | Tetanus toxin polypeptides | |
EP1232154A4 (en) | PROTEASE INHIBITORS |